Martin Marietta Materials, Inc.
MLM - NYSE - $606.10 ▲ +%0.47
-
Earnings Thu 6 Aug

Martin opens the
books on Thursday evening.

12 analysts' median target is $696[FMP target], stock is $606, +14.8% upside potential. After Q1 +8.4% EPS beat[FMP earnings], the stock moved -0.7%.

summary below
Quick Take - in 40 seconds
A-
HOLD Council 2/6 - Moonshot 30

A- = MoonshotScore 30[9-pillar formula] + Council 2/6[6-lens rule]. Form 4: 0 transactions[FMP Form 4].

Q1 consensus: revenue $1.9B[FMP est], EPS $5.14[FMP est]. 1 consecutive quarters of beat[FMP earnings].

$5.14 EPS Estimate Last year $1.93 - -5% YoY YoY
1 Beat Streak Expectations beaten consecutively for the last 1 quarters

Q1 EPS +8.4% beat[FMP] but the stock -0.7% D+1[FMP D+1]. Michael Petro promised $186.0M CapEx + a sequential decline in Q1 during the Q1 earnings call[Michael Petro capex transcript].

Watchlist

6 metrics stand out this quarter.

$143 million Investor Focus

Specialties Business Growth

specialties_business_growth

Martin Marietta's Specialties business achieved record revenues of $143 million, up 63% year-over-year.

"Our Specialties business also achieved new all-time quarterly records with revenues of $143 million, up 63% year-over-year and gross profit of $45 million, an increase of 17%."

- C. Nye - Q1 FY26 Earnings Call - April 30, 2026
2026 Expectation / Guide

Full Year Ebitda Guidance

full_year_ebitda_guidance

Martin Marietta reaffirmed its full year 2026 adjusted EBITDA guidance of $2.43 billion.

"With April's continued strong product demand, the impact of April 1 price increases and ongoing optimization efforts, we're reaffirming our full year 2026 adjusted EBITDA from continuing operations guidance of $2.43 billion at the midpoint."

- C. Nye - Q1 FY26 Earnings Call - April 30, 2026
%17 Investor Focus

Record Revenue

record_revenue

Martin Marietta reported record first quarter revenues of $1.4 billion, a 17% increase.

"2026 is off to a strong start with revenues increasing an impressive 17% to $1.4 billion, a new first quarter record."

- C. Nye - Q1 FY26 Earnings Call - April 30, 2026
$450 million Investor Focus

Quikrete Asset Exchange

quikrete_asset_exchange

Martin Marietta's Quikrete Asset Exchange shifted the portfolio away from more cyclical cement and concrete assets, providing $450 million of cash.

"Importantly, this transaction accelerated our aggregate sludge strategy by shifting the portfolio away from more cyclical cement and concrete assets, enhancing the quality and durability of our earnings profile, while providing $450 million of cash to redeploy into aggregate acquisitions accordingly."

- C. Nye - Q1 FY26 Earnings Call - April 30, 2026
7.2% Investor Focus

Organic Aggregate Shipments

organic_aggregate_shipments

Martin Marietta's organic aggregate shipments grew by 7.2%, exceeding guidance.

"Organic aggregate shipments growth of 7.2% meaningfully exceeded our guidance, benefiting from an early start to the construction season in the Midwest and Colorado as well as continued strength in infrastructure and heavy nonresidential demand across our geographic footprint."

- C. Nye - Q1 FY26 Earnings Call - April 30, 2026
8 million Investor Focus

New Frontier Materials Acquisition

new_frontier_materials_acquisition

Martin Marietta entered into a definitive agreement to acquire New Frontier Materials, which produces over 8 million tons of aggregates annually.

"And consistent with the company's SOAR 2030 strategic plan, on April 19, we entered into a definitive agreement to acquire New Frontier materials, a complementary bolt-on to our central division that produces over 8 million tons of aggregates annually."

- C. Nye - Q1 FY26 Earnings Call - April 30, 2026

Stock Expert AI - Methodology

Do our 9 pillars, 7 perspectives, and Munger lens point in the same direction?

Council Score 2 / 6 Bullish

6 investor frameworks. 2 bullish (Ray Dalio, Buffett), 1 bearish (Ken Griffin), 3 neutral (Jim Simons, Klarman, Munger).

How is it calculated? ->
Ray Dalio macro - target upside +14.8%
Ken Griffin flow - 50d MA below
Jim Simons quant - RSI 47
Klarman value - target upside +14.8%
Buffett quality - ROE score 5/5
Munger valuation - target upside +14.8%
Munger's Mindset character & balance sheet lens
Fairly Valued

Quality business, trading at fair value.

How is it calculated? ->
Financial HealthStrong
Margin of SafetyModerate
Interest CoverageAdequate
ROIC vs WACCHealthy
Technical Levels - Pre-earnings positioning

What levels is the stock being tested at?

RSI(14)
46.5 RSI 46.5 balanced, 50d below
MACD
-1.00 price below 50d - resistance dominant
50d MA
$612 stock 1.0% below - short-term resistance
200d MA
$622 stock 2.5% below - long-term pressure
Volume (10d)
-9% decrease - low participation
Resistance
$696
Analyst median target - upgrade trigger if broken
Current
$606
Pre-earnings position
Support
$529
Invalidation - close below this is a technical breakdown
Pattern
Range
$529-$696 band - earnings breakout/breakdown trigger

Past Performance

Martin's last 8 quarters: 1 consecutive beats.

BEAT
Q2 FY25
$5.43 vs $5.31 est - +1.8%
MISS
Q3 FY25
$5.97 vs $6.72 est - -2.3%
MISS
Q4 FY25
$3.85 vs $4.78 est - -0.2%
BEAT
Q1 FY26
$1.93 vs $1.78 est - -0.7%

Q1 (April 30, 2026): EPS $1.93 vs $1.78 est[FMP], +8.4% beat. D+1 movement: -0.7%[FMP D+1]. Decline despite beat - market reacted to guidance, not numbers.

Three scenarios: what could happen?

EPS < $4.99 (no guidance)

Q1: EPS $1.93 vs $1.78 beat[FMP], stock -0.7% D+1[FMP].

Backlog concentration

No RPO/backlog concentration disclosed in Q1 earnings call.

CapEx shock

Q1 CapEx $186.0M[FMP cashflow]. Q1 op margin 11.9%[FMP op margin] - this level in Q1 is sensitive to CapEx revision risk.

Framework - Position discipline

After the data arrives: 3 scenarios, 3 windows

Not advice - a structural framework for earnings night. Decision discipline is yours.

Scenario A - Beat
Q1 EPS > $5.14 + CapEx discipline
Threshold: EPS > $5.14[FMP est].
Target: Break above median target $696[FMP target]; high target $785[FMP] upper bound.
Scenario B - In-Line
EPS approx $5.14 + CapEx < $186.0M
Threshold: EPS approx $5.14[FMP est], Q1 CapEx < $186.0M[FMP].
Target: Consolidation in the band between current $606[FMP] and median $696[FMP].
Scenario C - Miss
EPS < $4.99 or CapEx >= $186.0M
Threshold: EPS < $4.99[FMP estx0.97].
Target: Current $606 below SMA200 $622[FMP], if rejection continues, $529[derived] support activates.
Sizing
Earnings volatility -> max portfolio 1-2%. Waiting for earnings is not a gamble, it's a position entrustment.
Timing
IV crush within 24 hours post-earnings. Waiting for premium decay makes options preferable to spot.
Staging
Don't go all-in at once, divide into 3: initial reaction, 24 hours later, after Friday's close.

Market Outlook

What do 12 analysts say?

Wall Street Consensus
$696
12-month median target price (+14.8% upside potential)
14
BUY
7
HOLD
1
SELL
Risk Management
$529
Invalidation level - critical support threshold
$612 - 50-day MA (below, -1.0%)
$622 - 200-day MA (below, -2.5%)
IV Crush risk (sudden drop in inflated option premiums before earnings): Option premiums are inflated before earnings.
Verdict - MLM Q1 FY27
A-

You read it in 5 minutes. When the numbers come out on Thursday evening - you know what you're looking at.

Data arrives at night. The framework is ready now.

Data arrives on Thursday evening. The framework is ready on this page: Q1 EPS threshold $5.14[FMP], CapEx threshold "below $186.0M"[Michael Petro]. Two anchors, three scenarios.

Comparison Stock Expert AI Pro $24/month ($240/year), 77% cheaper than the total of three earnings-tracking tools ($1,059/year -> $240/year).

3 subscriptions. 1 platform.

Seeking Alpha $299/yr - analyst opinions + earnings coverage TipRanks $360/yr - Smart Score (1-10) + analyst consensus + insider trades Trendspider $400/yr - AI pattern detection + automated TA + multi-timeframe alerts

Prices as of April 2026. Sources: seekingalpha.com/subscriptions - tipranks.com/pricing - trendspider.com/pricing

Stock Expert AI Pro: $24/month ($240/year). Council 7-lens analysis + MoonshotScore 9-pillar + Insider tracker + Technical levels - all in one platform, for every stock.

Educational tool, not investment advice. Past performance does not guarantee future results.

Calendar

Catalyst Calendar - 90-day forward look

Aug 6, 2026EARNINGSQ1 FY27 results (after market close) + earnings call
Aug 7, 2026PRICEFirst trading day after earnings - 200dMA test + IV crush
Sep 20, 2026FILING10-Q deadline - segment breakdown + RPO detail (SEC rule: quarter-end + 45 days)
~Nov 6, 2026EARNINGSQ2 FY27 (next quarter, date not yet scheduled in FMP)

DATA GAP: Events not in the FMP /stable/calendar feed - Investor day, analyst day, product launches, regulatory dates. These require company IR page scraping or manual calendar entry.

Frequently Asked Questions

What does the MLM earnings preview cover?

This MLM (MLM) earnings preview covers the analyst consensus, key catalysts, and what to watch on the earnings call.

What should investors watch for in MLM earnings?

Consensus EPS, revenue guidance, segment growth rates, and the tone of management commentary — the full breakdown with sources is on this page.